TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Yingkun XuGuangzhen WuJiayao ZhangJianyi LiNingke RuanJianfeng ZhangZhiyu ZhangYougen ChenQi ZhangQinghua XiaPublished in: BioMed research international (2020)
TRIM33 exhibits an abnormally low expression in human ccRCC tissues. TRIM33 may serve as a potential therapeutic target and prognostic marker for ccRCC.